VAERS Explorer
Back to explore

Report #2878043

Received Dec 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLULAVAL)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (2)

Occupational exposure to productProduct container issue

Symptom narrative

Flulaval vial broke while administering and broke on employees finger; Flulaval vial broke while administering and broke on employees finger; Flulaval vial broke while administering and broke on employees finger; Flulaval vial broke while administering and broke on employees finger; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of occupational exposure via skin contact with product in a patient who received Flu Seasonal TIV Quebec (Flulaval) for prophylaxis. This case was associated with a product complaint. On an unknown date, the patient received Flulaval. On an unknown date, an unknown time after receiving Flulaval, the patient experienced occupational exposure via skin contact with product (Verbatim: Flulaval vial broke while administering and broke on employees finger), device breakage (Verbatim: Flulaval vial broke while administering and broke on employees finger), product leakage (Verbatim: Flulaval vial broke while administering and broke on employees finger) and pharmaceutical product complaint (Verbatim: Flulaval vial broke while administering and broke on employees finger). The outcome of the occupational exposure via skin contact with product, device breakage, product leakage and pharmaceutical product complaint were not applicable. It was unknown if the reporter considered the device breakage to be related to Flulaval and Flulaval Pre-Filled Syringe Device. It was unknown if the company considered the device breakage to be related to Flulaval and Flulaval Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-DEC-2025 This case was reported by a patient via interactive digital media. The Flulaval vial broke while administering and broke on employees finger. The batch number was not provided and unable to contact the reporter.